Autopsy report · NCT05415696
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Cause of deathSlow enrollment
“Enrolling to this clinical trial was too difficult”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer
- Interventions
- Prostatic artery embolization
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers
“clinical trial have encountered difficulties enrolling a sufficient number of patients” - Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT
“Difficulty in enrolling the required number of participants has made it impractical to proceed with the trial.” - Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias
“Clinical trial was halted prematurely due to low enrollment” - Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery
“for difficulty to enroll patients in the study” - Inpatient Mortality Prediction Algorithm Clinical Trial (IMPACT)
“This trial did not start. No participants enrolled”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.